{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:42:37Z","timestamp":1789674157929,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ejca.2022.10.014","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T02:13:52Z","timestamp":1666750432000},"page":"171-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Real-time drug testing of paediatric diffuse midline glioma to support clinical decision making: The Zurich DIPG\/DMG centre experience"],"prefix":"10.1016","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4702-7142","authenticated-orcid":false,"given":"Timothy","family":"Mueller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Laternser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3136-9241","authenticated-orcid":false,"given":"Ana S.","family":"Guerreiro St\u00fccklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1783-631X","authenticated-orcid":false,"given":"Nicolas U.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulayman","family":"Mourabit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Rizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7616-6320","authenticated-orcid":false,"given":"Elisabeth J.","family":"Rushing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0166-2770","authenticated-orcid":false,"given":"Raimund","family":"Kottke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Grotzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklaus","family":"Krayenb\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3452-5150","authenticated-orcid":false,"given":"Sabine","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12 Suppl. 2","key":"10.1016\/j.ejca.2022.10.014_bib1","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2022.10.014_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fonc.2015.00237","article-title":"DIPG in children \u2013 what can we learn from the past?","volume":"5","author":"Vanan","year":"2015","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2022.10.014_bib3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2022.10.014_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejca.2019.03.019","article-title":"Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience","volume":"114","author":"Pfaff","year":"2019","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.ejca.2022.10.014_bib5","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/neuonc\/noy070","article-title":"Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma","volume":"20","author":"Gupta","year":"2018","journal-title":"Neuro Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2022.10.014_bib6","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00381-015-2832-1","article-title":"Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomas","volume":"31","author":"Puget","year":"2015","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.ejca.2022.10.014_bib7","first-page":"1","article-title":"Robot-assisted stereotactic biopsy of pediatric brainstem and thalamic lesions","author":"Gupta","year":"2020","journal-title":"J Neurosurg Pediatr"},{"issue":"7","key":"10.1016\/j.ejca.2022.10.014_bib8","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/ijc.32258","article-title":"A pilot precision medicine trial for children with diffuse intrinsic pontine glioma-PNOC003: a report from the Pacific Pediatric Neuro-Oncology Consortium","volume":"145","author":"Mueller","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2022.10.014_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejca.2016.06.009","article-title":"Next-generation personalised medicine for high-risk paediatric cancer patients \u2013 the INFORM pilot study","volume":"65","author":"Worst","year":"2016","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2022.10.014_bib10","first-page":"921","article-title":"Diagnostic utility of oncomine comprehensive assay v3 in differentiating between isocitrate dehydrogenase (IDH)-mutated grade II-III astrocytoma and oligodendroglioma","volume":"35","author":"Kim","year":"2021","journal-title":"In\u00a0Vivo"},{"issue":"5","key":"10.1016\/j.ejca.2022.10.014_bib11","first-page":"699","article-title":"Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy","volume":"19","author":"Kline","year":"2017","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2022.10.014_bib12","first-page":"vdab169","article-title":"Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma","volume":"3","author":"Duchatel","year":"2021","journal-title":"Neurooncol Adv"},{"issue":"9","key":"10.1016\/j.ejca.2022.10.014_bib13","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/neuonc\/noac041","article-title":"Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas","volume":"24","author":"Przystal","year":"2022","journal-title":"Neuro Oncol"},{"issue":"Suppl._2","key":"10.1016\/j.ejca.2022.10.014_bib14","article-title":"CTNI-27. FIRST-IN-PEDIATRICS PHASE I STUDY OF GDC-0084 (PAXALISIB), A CNS-PENETRANT PI3K\/mTOR INHIBITOR, IN NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) OR OTHER DIFFUSE MIDLINE GLIOMA (DMG)","volume":"22","author":"Tinkle","year":"2020","journal-title":"Neurooncology"},{"issue":"3","key":"10.1016\/j.ejca.2022.10.014_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3171\/2017.2.PEDS1665","article-title":"Update on the diagnostic value and safety of stereotactic biopsy for pediatric brainstem tumors: a systematic review and meta-analysis of 735 cases","volume":"20","author":"Hamisch","year":"2017","journal-title":"J Neurosurg Pediatr"},{"issue":"5","key":"10.1016\/j.ejca.2022.10.014_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/15592294.2016.1278095","article-title":"Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: insight into epigenetic therapies","volume":"12","author":"Maury","year":"2017","journal-title":"Epigenetics"},{"issue":"5","key":"10.1016\/j.ejca.2022.10.014_bib17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ccr.2013.10.006","article-title":"Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas","volume":"24","author":"Bender","year":"2013","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.ejca.2022.10.014_bib18","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00401-020-02142-w","article-title":"Histone H3 wild-type DIPG\/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation","volume":"139","author":"Castel","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"8","key":"10.1016\/j.ejca.2022.10.014_bib19","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2022.10.014_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11940-020-00651-3","article-title":"Advances in targeted therapies for pediatric brain tumors","volume":"22","author":"Mueller","year":"2020","journal-title":"Curr Treat Options Neurol"},{"issue":"1","key":"10.1016\/j.ejca.2022.10.014_bib21","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41467-019-08823-9","article-title":"ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis","volume":"10","author":"Hoeman","year":"2019","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.ejca.2022.10.014_bib22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccell.2020.11.013","article-title":"Arsenic trioxide rescues structural p53 mutations through a cryptic allosteric site","volume":"39","author":"Chen","year":"2021","journal-title":"Cancer Cell"},{"issue":"44","key":"10.1016\/j.ejca.2022.10.014_bib23","doi-asserted-by":"crossref","first-page":"76644","DOI":"10.18632\/oncotarget.19656","article-title":"Patient-derived DIPG cells preserve stem-like characteristics and generate orthotopic tumors","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ejca.2022.10.014_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11060-018-03038-2","article-title":"International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma","volume":"141","author":"Tsoli","year":"2019","journal-title":"J Neuro Oncol"},{"issue":"16 Suppl.","key":"10.1016\/j.ejca.2022.10.014_bib25","article-title":"Abstract CT205: phase 2 study to evaluate the safety, pharmacokinetics, and clinical activity of the PI3K\/mTOR inhibitor paxalisib (GDC-0084) in glioblastoma (GBM) with unmethylated O6-methylguanine-methyltransferase (MGMT) promotor status","volume":"80","author":"Wen","year":"2020","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.ejca.2022.10.014_bib26","article-title":"Neurocytological advances in the treatment of glioblastoma multiforme","volume":"13","author":"Fiani","year":"2021","journal-title":"Cureus"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922013090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922013090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:39:27Z","timestamp":1760733567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804922013090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":26,"alternative-id":["S0959804922013090"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2022.10.014","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-time drug testing of paediatric diffuse midline glioma to support clinical decision making: The Zurich DIPG\/DMG centre experience","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2022.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}